Biodegradable gel being studied as a treatment for esophageal cancer
Wednesday, April 15, 2009 - 14:42
in Health & Medicine
(CHICAGO) - Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. The unique drug therapy delivers a highly concentrated dose of chemotherapy injected directly on to the hard-to-reach tumors in the esophagus non-surgically.